Key result
Inactivation of PTEN or treatment with IGF-1 enhanced cardiac L-type Ca2+ currents via a PI3Kalpha-dependent increase in PKB activation (P<0.01 for PTEN-/- vs controls).
Population
Myocytes isolated from mice overexpressing a dominant-negative p110alpha mutant in the heart, lacking the…
Comparison
Inactivation of PTEN or application of… vs Littermate controls or untreated myocytes.
Design
Preclinical
Authors
Loading...
p110α loss reduces I(Ca,L) and contractility in mice; leaves open its therapeutic relevance in human HF.
p-value: p=<0.01
IGF-1 treatment or inactivation of PTEN enhances cardiac L-type Ca2+ currents via a PI3Kalpha-dependent increase in PKB activation.
Sun et al. (2006) studied this question. PTEN deletion and IGF-1 application vs. Littermate controls was evaluated on Basal I(Ca,L) densities (p=<0.01). Inactivation of PTEN or treatment with IGF-1 enhanced cardiac L-type Ca2+ currents via a PI3Kalpha-dependent increase in PKB activation (P<0.01 for PTEN-/- vs controls).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: